Carrick Therapeutics

Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated. The company's therapeutics target molecular pathways that drive the most aggressive and resistant forms of cancer using innovative mechanisms, enabling cancer patients to get their predictive biomarkers detected and get their treatments started from early stage.

Carrick Therapeutics headquartered in Europe, operates in the Biotechnology, Health Care, Pharmaceutical, Therapeutics sector. The company focuses on Biotechnology and has secured $5.0B in funding across 32 round(s). With a team of 1-10 employees, Carrick Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Carrick Therapeutics, raised $95.0M. Discover more about their projects, partnerships, and impact on our platform.